QuickViews

Rovi

Enoxaparin biosimilars - natural evolution

Pharmaceutical & healthcare | 15/06/2017

Rovi, a Spain-domiciled, speciality pharma company, plans to launch an enoxaparin biosimilar (originator: Sanofi Clexane/Lovenox) into key European markets…

Therapix Bioscience

Cannabinoids for underserved diseases

Pharmaceutical & healthcare | 07/06/2017

Therapix recently underwent an IPO on NASDAQ in the US of 2.3m ADS (worth $13.8m) to finance the clinical development of cannabinoid products. The lead…

Cranswick

Making gains in a competitive space

Consumer Support Services | 26/05/2017

Cranswick has posted yet another year of strong growth. The business is witnessing growth in all its categories and strong innovation is keeping its offering…

aap Implantate

Solid start to 2017

Pharmaceutical & healthcare | 18/05/2017

aap Implantate has announced a solid start to 2017 with Q1 trauma sales increasing by 30% to €2.9m and total sales up 23% to €3.1m, slightly…

The Marketing Group

New board, strategy being refreshed

Technology | 16/05/2017

The Marketing Group (TMG) achieved revenues of €7.2m and an EBITDA of €0.125m in Q117, with the strong performance by the majority of group…

About QuickViews

Edison meets over 1,000 companies a year. Edison QuickViews are produced where our analyst has not taken up formal coverage, but has a good understanding of the company. QuickViews are normally one-off publications with no commitment to writing any follow up. Our QuickView notes use consensus earnings estimates.

More QuickViews

PDF icon
aap Implantate

Solid start to 2017

Pharmaceutical & healthcare | 18/05/2017
PDF icon
The Marketing Group

New board, strategy being refreshed

Technology | 16/05/2017
PDF icon
Good Energy Group

Responsibly sourced shareholder value

General Industrials | 11/05/2017
PDF icon
Smith & Nephew

Continuing to focus on execution

Pharmaceutical & healthcare | 10/05/2017
PDF icon
Canacol Energy

Positioned to sustain growth in 2017

Oil & Gas | 08/05/2017
PDF icon
BioLineRx

Multiple shots on goal and multiple partners

Pharmaceutical & healthcare | 04/05/2017